# Safety Study of Tezepelumab (AMG 157) in Healthy Adults

> **NCT00972179** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 49 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Placebo
- **DRUG:** Tezepelumab

## Key facts

- **NCT ID:** NCT00972179
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-15
- **Primary completion:** 2011-01-09
- **Final completion:** 2011-01-09
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00972179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00972179, "Safety Study of Tezepelumab (AMG 157) in Healthy Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00972179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*